Increased expression of ADAM12 was detected in activated HSCs and in liver tissue sections from patients suffering from liver cirrhosis or HCC [105,106], suggesting that ADAM12 has a tumour-promoting role in the liver by actively remodelling the extracellular matrix. This evidence concerns the gene ADAM12 and hepatocellular carcinoma.